Truist Financial Corp Maravai Lifesciences Holdings, Inc. Transaction History

Truist Financial Corp

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 20, 2024	SELL	$6.87 - $11.34 $3,544 - $5,851	-516 Reduced 3.0%	16,673 $119,000
Q1 2024 May 10, 2024	BUY	$5.11 - $8.76 $10,838 - $18,579	2,121 Added 14.08%	17,189 $149,000
Q4 2023 Feb 02, 2024	SELL	$4.7 - $9.87 $20,581 - $43,220	-4,379 Reduced 22.52%	15,068 $98,000
Q3 2023 Nov 14, 2023	SELL	$9.14 - $12.85 $44,932 - $63,170	-4,916 Reduced 20.18%	19,447 $194,000
Q2 2023 Aug 01, 2023	BUY	$12.09 - $15.0 $12,694 - $15,750	1,050 Added 4.5%	24,363 $302,000
Q1 2023 May 05, 2023	BUY	$12.99 - $16.48 $302,835 - $384,198	23,313 New	23,313 $326,000
Q4 2021 Feb 14, 2022	SELL	$35.0 - $45.94 $204,855 - $268,886	-5,853 Closed	0 $0
Q3 2021 Nov 05, 2021	SELL	$36.8 - $60.62 $29,955 - $49,344	-814 Reduced 12.21%	5,853 $287,000
Q2 2021 Aug 16, 2021	BUY	$32.46 - $45.0 $216,410 - $300,015	6,667 New	6,667 $278,000

235

141M

223K

19.4K

Ticker MRVI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 131,540,000
Market Cap $739M
Description
Maravai LifeSciences Holdings, Inc., a life sciences company, provides products to enable the development of drug therapies, diagnostics, novel vaccines, and support research on human diseases in the United States and internationally. The company's products address the key phases of biopharmaceutical development and include nucleic acids for dia...

Get notified when there are updates to the investment portfolio of Truist Financial Corp, based on Form 13F filings with the SEC.

Stay updated on Truist Financial Corp with notifications on news.